After more than 30 years following the birth of Louise Brown, the field of assisted reproduction techniques (ART) is still burdened by low pregnancy rates and relatively high multiple pregnancy rates. Embryo selection is still based on morphological criteria and any new technologies that would increase the ability to identify the most viable gametes and embryos would certainly improve ART outcome. Metabolomic profiling of both gametes and embryos appears to be highly promising to achieve this goal. The review will focus on the several applications of metabolomics in ART, where this quantitative, non-invasive, rapid approach could result in the generation of metabolite markers with high clinical impact. Nevertheless, extensive validation studies are needed before embryo screening tests based on metabolomic profiling become available for clinical use.
Introduction
Delivery of a healthy offspring requires genetically and structurally normal gametes. The field of Assisted Reproduction Techniques (ART) would therefore greatly benefit of any technologies that could identify healthy oocytes, sperm or embryos, because this could in turn result in improved pregnancy rate and better pregnancy outcome.
Despite increasing knowledge on stimulation protocols aimed at achieving the best compromise between number and quality of oocytes in in vitro fertilization (IVF), only 10% of retrieved oocytes and less than 20% of transferred embryos result in the delivery of a baby (Nagy et al., 2009) .
In order to prevent IVF failures, the simultaneous transfer of multiple embryos is often performed, especially in those countries where legal limitations on embryo cryopreservation exist. Unfortunately this strategy leads to the most severe side effect of IVF: multiple pregnancy. In fact, more than 30% of ART pregnancies are twins or higher-order multiple gestations, and 51% of all ART neonates are the products of multiple gestations, with a significant impact on public health and costs (Wright et al., 2006) . The combination of low pregnancy rates with relatively high multiple pregnancy rates has been defined the "IVF paradox". To overcome this state of affairs, several countries introduced a restriction of the number of embryos to be transferred, but this policy is in clear contrast with the patients' desire to optimize the chance of pregnancy. A potential solution to this problem is to utilize better methods to select gametes and embryos.
To date, gametes used for fertilization or embryos chosen for transfer are selected according to their morphological appearance. Morphological assessment of embryo quality is quick and inexpensive, but it is highly subjective, having a high interand intra-observer variability (Baxter Bendus et al., 2006) . In addition, even normally appearing embryos may harbour genetic or epigenetic defects . The situation is even worse when oocytes are considered: different methods used to assess oocyte morphology, including polar body morphology (Ebner et al., 2000) , cytoplasm appearance (Ebner et al., 2006) , position and shape of the spindle (Madaschi et al., 2008) , zona pellucida thickness and birefringence (Shen et al. 2005; Montag et al., 2008) , have substantially failed in identifying the oocyte able to generate a high quality embryo and later a pregnancy.
Recently, a number of novel, quantitative, non-invasive, embryo "quality" tests based on the metabolomic profile of gametes and embryos have been introduced. Metabolites represent a small portion of all the molecules present in a cell, but they constitute the very end product of the cellular metabolism and can thus be correlated to function and response to environment. The aim of metabolomics in ART is to quantitatively measure metabolites (secreted by gametes or embryos) and to correlate their presence (or absence) to embryo metabolism and viability (Singh and Sinclair, 2007; Nagy et al., 2008) . This review will illustrate the evidence published as of today.
General principles of metabolomics
Following the sequencing of human genome, the science called "genomics" has shifted to the study of gene expression and function. The so-called "post-genomic era" includes all the emerging "omics" sciences, such as transcriptomics, proteomics and metabolomics. These investigations focus on different aspects of cellular metabolism (RNA, proteins, metabolites, respectively) in order to better define how organisms and systems work.
The concept of "metabolome" was introduced in 1998 (Oliver et al., 1998) to describe the substances forming the metabolite content of an organism. Fiehn referred to the term few years later (Fiehn et al., 2000) to define any small molecular weight compound (metabolite), hosted in a cell or organism, which participates in metabolic reactions and it is required for growth and maintenance of normal function. Metabolomics can be defined as a rapid, high-throughput technology for quantitative measurement of the metabolites present in cells, tissue body fluid or culture media.
The ultimate goal of the metabolomic approach is to quantitatively measure the entire metabolic content within a biological system. The advantage of this approach is the belief that metabolites represent the final downstream product of the genome. The central dogma of molecular biology describes, in fact, a linear unidirectional flow of information from genes to transcripts, to proteins, and finally to metabolites, which lie at the terminal end of this continuous stream. Because metabolites can be envisioned as the ultimate phenotypic product of gene, mRNA and protein activity, the comprehensive profiling of metabolites contained in body fluids or cells would reflect the health status of the individual.
Metabolomics aims at the complete inventory of all small molecules weighting less than 1 kDa contained in a cell. Metabolites include metabolic intermediates and small compounds such as fatty acids, glucose, cholesterol, ATP, hormones, signalling molecules and secondary metabolites.
Importantly, metabolites, via the continuous interaction with environment, offer a snapshot and "biomark" of the system under investigation. In fact, metabolomics not only defines the relationship between genotype and its resulting phenotype, but also clarifies the influence that stressful environmental conditions have on metabolism itself (Roessner and Bowne, 2009 ). The quantitative measurement of metabolites could thus reflect the status of a cellular system and its interaction with the surrounding environment.
The metabolomic approach has been utilized to investigate the physiological status of cells, tissues and organisms, to diagnose diseases, measure response to treatments, or to identify perturbed pathways due to disease or treatment (Roessner and Bowne, 2009; Nordstrom and Lewensohn, 2010) . However, the most valuable and promising clinical application of metabolomics is the discovery of biomarkers, i.e. the identification of individual metabolites (as a reflection of the alteration of endogenous metabolites and biosynthetic flux) present in the "disease" phenotype and different from the "control" phenotype. Biomarkers could be used to diagnose a disease, choose a therapy, evaluate the effect of a chosen therapy and monitor disease progression.
From these premises, it is apparent that the investigation of metabolites during ART procedures could have relevant clinical implications. In fact, the identification of biomarkers in ART could define gametes' quality and embryo viability, thus helping embryologists to achieve selection criteria alternative, or complementary, to morphologic ones.
Ideally, a metabolic biomarker should be measured in a sample obtained through non-invasive sampling. Therefore, body fluids such as plasma, serum, saliva, urine, are considered ideal for biomarker identification and monitoring (Ptolemy and Rifai, 2010) . In fact, the basic assumption of biomarkers is that physiological or diseasespecific molecules leak or are secreted into body fluids where they can be quantified. The same "fluidic approach" can be applied in ART to assess metabolites in a noninvasive fashion. In particular, 1) follicular fluid obtained at the time of oocyte retrieval and 2) media used for culturing gametes/embryos could be analyzed by metabolomics and used to link the gamete/embryo metabolomic profile to a particular phenotype of oocyte/embryo. The metabolomic embryonic or gamete culture profiling could therefore provide additional clues to other non invasive criteria, such as morphology, for improving gamete and embryo selection.
Metabolomics combines different sophisticated analytical technologies to identify and quantify cellular metabolites with statistical methods for information extraction and data interpretation.
The metabolomic experiment is, in fact, composed of different stages: experimental design, sample collection, sample preparation, sample analysis, preprocessing of raw data, data processing and analysis of processed data (Dunn et al., 2005) (Fig.1 ). As such, it requires a multidisciplinary team of scientists, chemists, biologists and informatics experts who collaborate in a meticulously planned workflow. An exact standard operating procedure (SOP) must be selected for each step of the pipeline in order to remove any potential bias and errors (Nordstrom and Lewensohn, 2010) .
Recent improvements in each of the above mentioned steps of the process (noninvasive sampling, standardized procedures, high-throughput techniques, data analysis software and bioinformatics tools, development of metabolite databases) have accelerated the measurement and identification of metabolites (Dunn et al., 2005) . In particular, advances in the technological hardware have led to more comprehensive profiling experiments, and novel deconvolution processing softwares have allowed the handling of larger amounts of raw data (Hocquette et al., 2009; Vinayavekhin et al., 2010) .
Metabolomic analysis can be achieved in a relatively short time, as the number of metabolites is much lower than the number of genes and proteins in a cell. In fact, it is generally agreed that the estimated size of the metabolome pool is 6500 metabolites (human metabolome project: www.hmdb.ca) as compared to the approximately 30,000 genes forming the human genome, and the 100,000-200,000 transcripts or 1 millions proteins (Fig. 2) .
Despite the great promises, metabolomics presents also several analytical challenges. Difficulties are inherent to a) the labile nature, short half-life, chemical complexity of metabolites; b) the lack of methods to reliably amplify metabolites and increase the sensitivity of the detection techniques; c) big heterogeneity of molecules to be identified with very different chemical properties.
Given the above challenges, it is not surprising that, as of today, there is not a single technique able to detect every single metabolite.
Sample preparation has to come to terms with the enormous heterogeneity represented by the metabolome and with the very low concentration of many molecules in the samples. Even though the estimated number of molecules is small when compared to the proteome or transcriptome, the metabolome is in fact more diverse in chemical and physical properties. The larger variation in atomic arrangements and the wide range of chemical species and concentrations can vary over nine orders of magnitude (from pM to mM). The dilution of potential markers in the relatively large volume of the body fluids may represent an additional limit of the technology.
Therefore, the sensitivity of metabolomic techniques should be carefully assessed before starting a study aimed at finding clinically relevant biomarkers. Cellular heterogeneity that arises from stochastic expression of genes, proteins and metabolites could increase the baseline noise level and could represent an insurmountable limit. Furthermore, changes of metabolic patterns, occurring physiologically, could potentially mask the molecular changes investigated in a given situation. Despite the significant success of metabolomics, these limits need to be carefully assessed and it is not yet possible to detect the whole population of metabolites in a system with a single analytical platform. Moreover, and independently to technological challenges, the environment itself is not always controlled and reproducible. Differences in age, sex, nutritional status, diurnal rhythms, lifestyle, disease and therapies, might be reflected in the metabolite composition of each body fluid. 
Multidisciplinary team
Rigorous planning of a metabolomic study relies on an accurate sample selection and preparation to ensure that sampling is reproducible from day-to-day and month-tomonth. Accurate selection of the population to be studied becomes another important key point in the study design.
Importantly, because metabolic reactions are short lived (in the order of 1 second) (Roessner and Bowne, 2009) , cellular metabolism has to be stopped as quickly as possible after collection of the specimen in order to obtain the most actual snapshot of the system. Tissue samples or fluids should be assessed immediately or snap-frozen in order to promptly stop metabolism and enzymatic activities.
Finally, another difficulty faced by researchers is the interpretation of the vast amount of data produced by high-throughput analyzers, together with the need to distinguish between noise and real samplerelated information. Metabolite identification in a biological context is a challenge even for a multidisciplinary team, since no databases which can predict metabolite structure from a genome sequence, as it happens for proteomic data, are available.
Mass spectrometry and different associated chromatographic separation techniques are the major tools to analyze a large number of metabolites simultaneously, but to-date no single technology is encompassing all challenges described above (Dunn et al., 2005; Roessner and Bowne, 2009) .
Technologies for metabolomic analysis
The techniques used in metabolomics must be sensitive and capable of screening a high number of heterogeneous molecules in a reasonably short time. Common technologies include mass spectrometry (MS) (alone or coupled with separation methods), nuclear magnetic resonance (NMR) spectroscopy and optical spectroscopies, like Fourier transform infrared (FT-IR), near infrared (NIR) and Raman spectroscopies (Dunn et al., 2005; .
Fig. 2:
Post-genomic era (modified from Nagy et al., 2008) genes ~30,000 GENOME mRNA ~200,000 TRANSCRIPTOME proteins ~1,000,000 PROTEOME metabolites ~6,500 METABOLOME "POST-GENOMIC ERA": towards phenotype An alternative are the relatively inexpensive and simple platforms of optical spectroscopies. These techniques measure the vibrations and rotations of molecular functional groups that result from the energy exchange when electromagnetic radiation (depending on its wavelength) interacts with a sample. Instrumentation is relatively simple, extremely stable over time and can be used by minimally trained personnel.
A summary of the available techniques used in metabolomic studies, together with their advantages and disadvantages, is shown in Fig. 3 and Table 1 .
Application of metabolomics to reproductive medicine
Morphological assessment of gametes and embryos has modest predictive power and high inter and intra-observer variability (Boyer and Boyer, 2009 ).
These limitations have spun investigations for alternative methods of embryo viability assessment: evaluation of respiration rate, analysis of culture media and metabolomics applied to both gametes and embryos (Aydiner et al., 2010) . The hope of these techniques is to be able to identify the healthiest oocyte or embryo that will result in a successful pregnancy.
Because metabolomic analysis can provide information with high accuracy and at lower costs than genomics, transcriptomics or proteomics, it is well suited for widespread investigations in the life sciences and ART.
The adoption of metabolomics in ART is a recent phenomenon. A PubMED search for the term "metabolomics", between 2006 and 2011, revealed a total of 2361 published articles, with 761 published in the last year. Of the human metabolomic studies listed in this review 16 out of 26 were published later than 2007. It is hoped that this rapid utilization of the technology will result in the generation of metabolite markers with high clinical impact.
The study of the endometabolomes, i.e. the metabolites contained inside a cell, requires cellular sampling or embryo biopsy, and it is therefore of limited value when gametes or embryos are considered. Analysis of cellular metabolites could be however performed in an abnormal embryo or excess normal embryo being discarded or in blastomeres obtained during pre-implantation genetic diagnosis and screening (PGD and PGS).
More advantageous from a practical point of view is the analysis of the metabolites secreted in the extracellular environment, the so called "secretome" of fluids (such as seminal plasma, oocyte/embryo culture medium or follicular fluid . This type of detection requires a noninvasive procedure, but can still reflect the phenotype or cell function.
Identifying key biomarkers, together with biomarker patterns of oxidative stress in the culture media of the developing embryo or in the microenvironments (i.e. follicular fluid or seminal plasma), could allow a rapid 
Metabolomic assessment of human embryos
The majority of metabolomic studies in ART has focused on assessing embryo quality and viability in the spent culture media. These studies are based on the assumption that embryos which result in a pregnancy have a different metabolic profile than embryos not able to implant.
Amino-acid turnover of the spent medium measured with HPLC was shown to improve the selection of viable embryos to be transferred; in particular, higher levels of leucine and glycine and lower levels of asparagine in the embryo media are significantly correlated with successful cycles (Brison et al., 2004) . Other noninvasive investigations of the spent embryo culture media showed interesting implications of metabolism in embryo assessment and IVF outcomes (Sakkas and Gardner, 2005) . Once tested the glycolytic activity of blastocyst culture media trough quantitative microfluorescence (Lane and Gardner, 1996) , it was shown that blastocysts with a lower glycolysis are more viable.
Another study, using gaschromatography and combustion-isotoperatio mass spectrometry, showed that the percentage of unsaturated fatty acids correlates with the rate of developing embryos (Haggarty et al., 2006) . The technologies used to measure these metabolites are however complex, laborious and require dedicated technical staff resulting in high costs. In addition, these technologies need a lengthy processing time and can not be used clinically in the limited time window before transfer, unless embryos are frozen and used in a subsequent thawing cycle.
On site, metabolic approaches towards the comprehensive analysis of the metabolome seem more promising: recently the groups of Nagy and Botros focused on this more extensive approach using Raman and NIR spectroscopy (Nagy et al., 2008; Seli et al., 2008 and .
One of the first prospective multi-centre study showed that non-invasive metabolomic profiling of human embryo culture media correlated with pregnancy outcome (Seli et al., 2007) . In particular, the ratio of spectral regions containing or not an hydroxyl group (R-H/R-OH) in the media was found to reflect oxidative stress and the associated spectral regions discriminated embryo viability. Raman and NIR spectroscopy predicted pregnancy outcome with a sensitivity of 76.5% and 83.3% and a specificity of 86% and 75%, respectively (Seli et al., 2007) . The findings were confirmed in a prospective blinded study (Scott et al., 2008) and metabolomic profiling resulted more accurate to assess viable embryos than morphological selection (53.6% vs. 38.5%, respectively) (Vergouw et al., 2008) . A more recent study used NMR spectroscopy to assess metabolomic profiling of embryo culture media (Seli et al., 2008) . Findings showed that glutamate concentrations were significantly higher in culture media of day-3-embryos that resulted in pregnancy, with a sensitivity of 88.2% and a specificity of 88.2%.
These results suggest that in vitro cultured embryos with a high reproductive potential alter their environment differently compared with embryos that do no result in a pregnancy.
Of course type and volume of the medium, culture times and days of embryo transfer influence results. These parameters should be uniformed if different studies are compared, even though a recent crossvalidation study showed that metabolomic profiling may not be restricted to a specific set of culturing conditions (Ahlström et al., 2011) . Furthermore, we must underline that most of these studies are retrospective. Overall, they indicate that metabolomic profiling of embryo culture media is independent of embryo morphology, providing a new parameter of embryo viability assessment (Seli et al., 2010) . Nevertheless, these results need to be replicated in a prospective manner by different groups of investigators prior that the technology is widely adopted.
Metabolomic assessment of gametes
Metabolomics has been proposed as a rapid, non-invasive tool for investigating the health of male and female gametes. The role of metabolomics in male factor infertility has been recently reviewed (Deepinder et al., 2007) . Overall, metabolomic assessment of female gametes seems more promising.
Several European countries have a strict policy limiting the number of oocytes that can be fertilized or the number of embryos that can be transferred. Oocytes and embryo selection is therefore a fundamental help to the reproductive endocrinologist. The ability to determine oocyte quality prior to fertilization could provide a relevant alternative to embryo selection and would help sustaining IVF success rate reducing the moral problems raised by a surplus of fertilized eggs. Potentially, reliable oocyte selection may also screen gametes with altered developmental potential. In addition,
though not yet performed, metabolomic profiling of culture media could be used to assess the health of the oocyte during in vitro maturation (IVM) and could facilitate selection of oocytes to be frozen in cryopreservation programs.
Oocyte competence, or the ability of the oocyte to undergo meiotic maturation, fertilization and subsequent embryonic development, can not be scored visually. While nuclear competence (prophase 1, metaphase 1 and 2) is easily recognizable, cytoplasmic competence involves many developmental steps (meiotic competence, spindle formation, mitochondria activation, establishment of calcium internal stores, etc.) that can not be tested without destroying the oocyte. An interesting approach to assess oocyte quality has been the measurement of oocyte oxygen consumption as a measure of oocyte health. The group of Scott used the EmbryoScope for automated non-invasive oxygen consumption evaluation in single oocytes. Interestingly, the oocyte baseline respiration rate (BRR) (expressed in nanolitres of O2/hour at standard temperature and pressure) correlated with the nuclear maturity and volume of the oocyte, with age and basal FSH concentration of the woman, and with the chance of fertilization. Depletion of ovarian reserve associated with ageing was found to be reflected in the reduction of mitochondria intracellular redox potential and, thus, of oocyte respiration (Scott et al., 2008) .
A potential opportunity to understand oocyte quality could be represented in future by the metabolomic analysis of the granulose cumulus cells (CCs). These cells surround the oocyte, forming the cumulus-oocytecomplex (COC) and have different metabolic needs (potentially measurable by metabolomics) than the oocyte. For example, energy requirements of the CCs and the oocytes are different: oocytes are unable to transport l-alanine, can not synthesize cholesterol from acetate, and poorly metabolize glucose for energy production, while CCs metabolise the bulk of the glucose consumed by the COC and therefore supply the metabolic intermediates (such as pyruvate and lactate) to the oocyte (Sutton-McDowall et al., 2010) . Defects in oocyte metabolism can limit further development and can be reflected by alteration in CCs. For example, oocytes of type 1 diabetic mice have poor developmental competence; their COC are clearly abnormal, the follicles are of smaller size, and the CCs have aberrant nuclear maturation (Chang et al., 2005; Kim et al., 2007) . On a molecular level, there is a decreased gap-junction communication between oocyte and CCs due to a low expression of connexins (Ratchford et al., 2008) . Given the tight communication between the oocyte and COC, several studies have analyzed the global pattern of gene expression in CCs (Adriaenssens et al., 2010; Assou et al., 2010) . From a practical level, the high costs and lengthy analytical time required to perform these studies make them not affordable to the average IVF laboratory.
The culture medium where the oocyte is cultured prior to fertilization is an additional obvious non-invasive candidate for the analysis of oocyte health. Recently, metabolomic profiling of oocyte culture medium, obtained after a 3 hours incubation time, was tested using near infrared spectroscopy (Nagy et al., 2009) . The authors defined a final viability score, and the model produced a continuous scale of oocyte reproductive potential. Unique metabolomic profiles identified oocytes according to their nuclear maturation stage. More interestingly, three peaks in the NIR spectrum were identified as discriminatory for IVF outcomes. Different metabolic fingerprints in oocyte culture medium correlated, in fact, with subsequent embryo development at day 3 and day 5, as well as with a positive or negative hCG test. Importantly, 3 hours of oocyte culture were sufficient to generate unique metabolomic 'fingerprints' in the culture media; this length of time is clinically acceptable and does not alter the optimal time for ICSI procedure or insemination (Nagy et al., 2009 
Metabolomic assessment of follicular fluid
The easy availability of follicular fluid (FF) at the time of egg retrieval makes it an ideal candidate to gauge oocyte health.
Follicular fluid is a mixture of constituents synthesized in the follicular wall and of plasma transudate which accumulates during follicle growth. FF provides supply of nourishment to the oocyte and the granulosa cells and, being closely associated with the oocyte, could influence oocyte development (Eppig, 1991; Piñero-Sagredo et al., 2010) . Overall, there are minimal concentration gradients between the antral fluid and the blood. One obvious exception is represented by steroids levels, which have a remarkably higher concentration in FF than in the general circulation. Also FF lactate levels exceed those present in the blood; lactate, in fact, is an important energy source for the oocyte and accumulates during follicular growth under the control of gonadotropins (Gosden et al., 1990) . On the contrary, all essential amino-acids and most of the nonessential amino-acids have lower concentrations in FF than in plasma, except glutamate which is three-fold higher in FF (Jozwik et al., 2006) . Interestingly, glutamate is used in the very early stages of embryo development, and thus can be considered a protective agent against oxidative stress.
As shown in our recent review (Revelli et al., 2009) , many factors such as steroids, lipids, glycosaminoglycans, ions and several proteins and peptides are present in the FF and can both influence and reflect the maturational status of the oocyte. Importantly, FF composition changes during different stages of ovarian follicular development (Gérard et al., 2002; Bender et al., 2010) .
Previous studies have mainly focused on the hormonal composition of the FF -steroids, gonadotropins, prolactin, growth factors, myo-inositol and catecholamines (Piñero-Sagredo et al., 2010) -but its metabolic composition is unfortunately still relatively unknown. Several authors have investigated FF glucose content, since its levels reflect the interaction of the oocyte, CCs and FF (Sutton-McDowall et al., 2010) . In a physiological situation, the oocyte is exposed to variable FF glucose levels, but concentration too low (< 2.3 mM) or too high (> 10 mM) are detrimental to oocyte development (Sutton-McDowall et al., 2010) . Robker correlated FF glucose levels with IVF outcome in patients with different BMI, showing that different BMI were associated with different ovarian follicular microenvironment. Follicular development and hormone responsiveness may be impaired in obese women, since a high BMI resulted in alterations of FF composition, with higher levels of insulin, glucose and lactate. In particular, the high FF glucose levels could be held responsible for the poor oocyte quality, reflected in the smaller number of oocytes retrieved and the fewer embryos obtained (Robker et al., 2009) . Another important alteration identified in the follicular environment of obese patients is the markedly increased level of C-reactive protein, indicative of increased inflammatory reactivity and high reactive oxygen species (ROS) content. Oxidative stress is known to be associated with poor oocyte developmental outcome (Martin-Romero et al., 2008; Agarwal et al., 2008) . . An early metabolomic approach to the study of FF was performed by Thomas more than ten years ago using the Fourier transform infrared spectroscopy. This technique provides 'fingerprints' of all chemical components in the sample analysed. The analysis showed that spectra of FFs from large follicles form a homogeneous cluster, indicating a similar biochemical profile, while fluids from small follicles were very heterogeneous and distinct, reflecting differences in the maturational stage of these smaller follicles. The standard deviations in the metabolite values were also significantly greater in the small follicles than in the larger ones, and reflected an analogous pattern in the steroids concentration (Thomas et al., 2000) .
More recently, a study analysed metabolite composition of FF by using high resolution NMR spectroscopy (Piñero-Sagredo et al., 2010) in a reference population of 30 oocyte donors which was assumed to possess optimal oocyte quality. When spectra were compared, no appreciable variation in the position of glucose and lipids peaks was apparent. The authors found a correlation between some intermediaries of the energetic pathway; the importance of such relationship between glycolytic pathway and fatty acids synthesis could later lead to the identification of biomarkers of IVF outcome and this is the purpose of further studies. The study confirmed the importance of anaerobic metabolism in follicles, with close correlation between glucose, lactate and pyruvate levels; these findings support the conclusion that FF plays a role in providing energy sources (as lactate and pyruvate) to the oocyte. Differently to previous evidence reporting higher FF myo-inositol concentrations in good quality embryos (Chiu et al., 2002) , in the study of Piñero-Sagredo only a weak signal for myo-inositol was detected. Myo-inositol is physiologically involved in the energetic metabolic pathway and further studies need to confirm if this metabolite can be used as a biomarker of follicular quality and developing oocytes. Definitively, no individual metabolite concentration provides a marker able to precisely indicate the potential of the oocyte; nevertheless, some metabolites and metabolic pathways can be related in future to a better oocyte quality, to successful fertilisation and pregnancy (Piñero-Sagredo et al., 2010) .
Another potential useful application of metabolomic is the assessment of FF quality in small size follicles (< 12 mm) used for in vitro maturation of oocytes (IVM). The clinical demand for IVM is in fact increasing, especially in developing countries, because of the potential to greatly reduce dependency on gonadotropin simulation. Deeper knowledge of metabolites present in FF could therefore help optimize in vitro culture conditions of immature oocytes (Sutton et al., 2003) .
Conclusion
The goal of any IVF clinic is to achieve a singleton livebirth with minimal morbidity and a low level of complications (multiple gestation, ovarian hyperstimulation syndrome, etc.). Ideally, this goal could be reached with the use of optimal stimulation protocols, sufficient to obtain few top-quality oocytes from which top-quality embryos will derive. Unfortunately, today none of the steps leading to this successful goal has been fully reached: stimulation protocols still produce several oocytes that are unusable (immature, abnormal, etc.) , multiple oocytes are needed to obtain few good quality embryos and the definition of 'top-quality' embryo itself is elusive. It is well known, in fact, that morphologically top-scoring embryos often do not result in a pregnancy and, conversely, low-grade embryos according to morphology achieve pregnancy.
Metabolomics therefore is a potentially valuable approach to select gametes and embryos thanks to its unique characteristics: it is quantitative, non-invasive, rapid, reliable. In addition the technology is developing rapidly, a feature that is usually associated with reduction of costs in relatively short times. Furthermore, metabolomics could be flawlessly integrated with different techniques of gamete/ embryo assessment, such as morphology (Seli et al., 2011) , PGD/PGS or functional genomic testing (like genome or proteome profiling). Although several recent studies have been promising, extensive investigative and validation studies are needed before embryo screening tests based on metabolomics become available for routine use. Larger prospective studies are indeed required to further validate these methodologies in order to fully optimize their value as predictors of gamete and/or embryo quality.
